<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38336892</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>3389</StartPage><MedlinePgn>3389</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3389</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-53784-9</ELocationID><Abstract><AbstractText>Postural Orthostatic Tachycardia Syndrome (POTS) reflects an autonomic dysfunction, which can occur as a complication to COVID-19. Our aim was to examine gastrointestinal symptoms and gut microbiota composition in patients with POTS and post-acute COVID-19 syndrome (PACS), compared with controls. POTS patients (n&#x2009;=&#x2009;27), PACS patients (n&#x2009;=&#x2009;32) and controls (n&#x2009;=&#x2009;39) delivered fecal samples and completed a 4-day food diary, irritable bowel syndrome-severity scoring system (IBS-SSS), and visual analog scale for IBS (VAS-IBS). A total of 98 DNA aliquots were sequenced to an average depth of 28.3 million (M) read pairs (Illumina 2&#x2009;&#xd7;&#x2009;150 PE) per sample. Diversity and taxonomic levels of the microbiome, as well as functional abundances&#xa0;were calculated for&#xa0;POTS and PACS groups, then&#xa0;compared with controls. There were several differences in taxonomic composition between POTS and controls, whereas only the abundance of Ascomycota and Firmicutes differed between PACS and controls. The clinical variables total IBS-SSS, fatigue, and bloating and flatulence significantly correlated with multiple individual taxa abundances, alpha diversity, and functional abundances. We conclude that POTS, and to a less extent PACS, are associated with differences in gut microbiota composition in diversity and at several taxonomic levels. Clinical symptoms are correlated with both alpha diversity and taxonomic and functional abundances.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamrefors</LastName><ForeName>Viktor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden. viktor.hamrefors@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden. viktor.hamrefors@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Infection Medicine, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmqvist</LastName><ForeName>Madlene</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infection Medicine, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infection Medicine, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varjus</LastName><ForeName>Roosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinical Microbiomics, Symbion, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudjonsson</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Microbiomics, Symbion, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedorowski</LastName><ForeName>Artur</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5352-6327</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohlsson</LastName><ForeName>Bodil</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>501100003173</GrantID><Agency>Crafoordska Stiftelsen (Crafoord Foundation)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054972" MajorTopicYN="Y">Postural Orthostatic Tachycardia Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Functional profiling</Keyword><Keyword MajorTopicYN="N">Gut microbiota</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome (PACS)</Keyword><Keyword MajorTopicYN="N">Postural orthostatic tachycardia syndrome (POTS)</Keyword><Keyword MajorTopicYN="N">Taxonomic profiling</Keyword></KeywordList><CoiStatement>RV and AG are employed by Clinical Microbiomics, Symbion. The remaining authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>11</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38336892</ArticleId><ArticleId IdType="pmc">PMC10858216</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-53784-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-53784-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology and management. J. Int. Med. 2019;285(4):352&#x2013;366. doi: 10.1111/joim.12852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Hira R, Baker JR, Siddiqui T, Ranada SI, Soroush A, Karalasingham K, Ahmad H, Mavai V, Valani LM, Ambreen S, Bourne KM. Objective Hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can. J. Cardiol. 2023;39(6):767&#x2013;775. doi: 10.1016/j.cjca.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9733966</ArticleId><ArticleId IdType="pubmed">36509178</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, Stahlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: The Swedish experience. JACC Case Rep. 2021;3(4):573&#x2013;580. doi: 10.1016/j.jaccas.2021.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting&#x2014;Part 1. Auton. Neurosci. 2021;235:102828. doi: 10.1016/j.autneu.2021.102828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022;194(10):E378&#x2013;E385. doi: 10.1503/cmaj.211373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.211373</ArticleId><ArticleId IdType="pmc">PMC8920526</ArticleId><ArticleId IdType="pubmed">35288409</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahic JM, Hamrefors V, Johansson M, Ricci F, Melander O, Sutton R, et al. Malmo POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome. J. Intern. Med. 2023;293(1):91&#x2013;99. doi: 10.1111/joim.13566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13566</ArticleId><ArticleId IdType="pmc">PMC10087729</ArticleId><ArticleId IdType="pubmed">36111700</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan I, Issac PK, Rahman MM, Guru A, Arockiaraj J. Gut-brain axis a key player to control gut Dysbiosis in neurological diseases. Mol. Neurobiol. 2023;18:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37851313</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson AJ, Pachnis V, Prinz M. Boundaries and integration between microbiota, the nervous system, and immunity. Immunity. 2023;56(8):1712&#x2013;1726. doi: 10.1016/j.immuni.2023.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2023.07.011</ArticleId><ArticleId IdType="pubmed">37557080</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry TS, Senapati SG, Gadam S, Mannam HP, Voruganti HV, Abbasi Z, Abhinav T, Challa AB, Pallipamu N, Bheemisetty N, Arunachalam SP. The impact of microbiota on the gut-brain axis: Examining the complex interplay and implications. J. Clin. Med. 2023;12(16):5231. doi: 10.3390/jcm12165231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12165231</ArticleId><ArticleId IdType="pmc">PMC10455396</ArticleId><ArticleId IdType="pubmed">37629273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimwe JA, Breier N, Saleem M, Kastner PD, Kirabo A, Shibao CA. The gut microbiota and short-chain fatty acids profile in postural orthostatic tachycardia syndrome. Front. Physiol. 2022;13:879012. doi: 10.3389/fphys.2022.879012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.879012</ArticleId><ArticleId IdType="pmc">PMC9208699</ArticleId><ArticleId IdType="pubmed">35733987</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Neng Q, Li Y, Kang Y, Guo L, Huang X, et al. Gastrointestinal autonomic neuropathy exacerbates gut microbiota dysbiosis in adult patients with type 2 diabetes mellitus. Front. Cell Infect Microbiol. 2021;11:804733. doi: 10.3389/fcimb.2021.804733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.804733</ArticleId><ArticleId IdType="pmc">PMC8861497</ArticleId><ArticleId IdType="pubmed">35211420</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufvesson H, Hamrefors V, Roth B, Fedorowski A, Ohlsson B. Sociodemographic factors, nutritional status, and inflammatory markers in patients with postural orthostatic tachycardia syndrome. Acta Neurol. Scandinavica. 2023;17:2023.</Citation></Reference><Reference><Citation>Torabi P, Rivasi G, Hamrefors V, Ungar A, Sutton R, Brignole M, et al. Early and late-onset syncope: Insight into mechanisms. Eur. Heart J. 2022;43(22):2116&#x2013;2123. doi: 10.1093/eurheartj/ehac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac017</ArticleId><ArticleId IdType="pmc">PMC9170473</ArticleId><ArticleId IdType="pubmed">35139180</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22(4):e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Krausslich HG, Brockmann SO, Gopel S, Kindle G, et al. Post-acute sequelae of covid-19 six to 12 months after infection: Population based study. BMJ. 2022;379:e071050. doi: 10.1136/bmj-2022-071050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilholm C, Larsson E, Sonestedt E, Roth B, Ohlsson B. Assessment of a 4-week starch-and sucrose-reduced diet and its effects on gastrointestinal symptoms and inflammatory parameters among patients with irritable bowel syndrome. Nutrients. 2021;13(2):416. doi: 10.3390/nu13020416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020416</ArticleId><ArticleId IdType="pmc">PMC7911460</ArticleId><ArticleId IdType="pubmed">33525489</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 1997;11(2):395&#x2013;402. doi: 10.1046/j.1365-2036.1997.142318000.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.1997.142318000.x</ArticleId><ArticleId IdType="pubmed">9146781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson M, Ohlsson B, Ulander K. Development and psychometric testing of the visual analogue scale for irritable bowel syndrome (VAS-IBS) BMC Gastroenterol. 2007;7:16. doi: 10.1186/1471-230X-7-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-230X-7-16</ArticleId><ArticleId IdType="pmc">PMC1868742</ArticleId><ArticleId IdType="pubmed">17475020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasolli E, Asnicar F, Manara S, Zolfo M, Karcher N, Armanini F, Beghini F, Manghi P, Tett A, Ghensi P, Collado MC. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell. 2019;176(3):649&#x2013;662. doi: 10.1016/j.cell.2019.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.01.001</ArticleId><ArticleId IdType="pmc">PMC6349461</ArticleId><ArticleId IdType="pubmed">30661755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen HB, Almeida M, Juncker AS, Rasmussen S, Li J, Sunagawa S, et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 2014;32(8):822&#x2013;828. doi: 10.1038/nbt.2939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2939</ArticleId><ArticleId IdType="pubmed">24997787</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. CheckM: Assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res. 2015;25(7):1043&#x2013;1055. doi: 10.1101/gr.186072.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.186072.114</ArticleId><ArticleId IdType="pmc">PMC4484387</ArticleId><ArticleId IdType="pubmed">25977477</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357&#x2013;359. doi: 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert M, Lindgreen S, Orlando L. AdapterRemoval v2: Rapid adapter trimming, identification, and read merging. BMC Res. Notes. 2016;9:88. doi: 10.1186/s13104-016-1900-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-016-1900-2</ArticleId><ArticleId IdType="pmc">PMC4751634</ArticleId><ArticleId IdType="pubmed">26868221</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754&#x2013;1760. doi: 10.1093/bioinformatics/btp324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp324</ArticleId><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantalapiedra CP, Hernandez-Plaza A, Letunic I, Bork P, Huerta-Cepas J. eggNOG-mapper v2: Functional annotation, orthology assignments, and domain prediction at the metagenomic scale. Mol. Biol. Evol. 2021;38(12):5825&#x2013;5829. doi: 10.1093/molbev/msab293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msab293</ArticleId><ArticleId IdType="pmc">PMC8662613</ArticleId><ArticleId IdType="pubmed">34597405</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerta-Cepas J, Szklarczyk D, Heller D, Hern&#xe1;ndez-Plaza A, Forslund SK, Cook H, Mende DR, Letunic I, Rattei T, Jensen LJ, von Mering C. eggNOG 5.0: A hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses. Nucl. Acids Res. 2019;47(D1):D309&#x2013;D314. doi: 10.1093/nar/gky1085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1085</ArticleId><ArticleId IdType="pmc">PMC6324079</ArticleId><ArticleId IdType="pubmed">30418610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acids Res. 2000;28(1):27&#x2013;30. doi: 10.1093/nar/28.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira-Silva S, Falony G, Darzi Y, Lima-Mendez G, Garcia Yunta R, Okuda S, et al. Species-function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 2016;1(8):16088. doi: 10.1038/nmicrobiol.2016.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.88</ArticleId><ArticleId IdType="pubmed">27573110</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Preez S, Corbitt M, Cabanas H, Eaton N, Staines D, Marshall-Gradisnik S. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis. Syst. Rev. 2018;7(1):241. doi: 10.1186/s13643-018-0909-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-018-0909-0</ArticleId><ArticleId IdType="pmc">PMC6302292</ArticleId><ArticleId IdType="pubmed">30572962</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M, Borrelli O, Saliakellis E, Thapar N. Gastrointestinal neuropathies: New insights and emerging therapies. Gastroenterol. Clin. North. Am. 2018;47(4):877&#x2013;894. doi: 10.1016/j.gtc.2018.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gtc.2018.07.011</ArticleId><ArticleId IdType="pubmed">30337038</ArticleId></ArticleIdList></Reference><Reference><Citation>Patist CM, Stapelberg NJC, Du Toit EF, Headrick JP. The brain-adipocyte-gut network: Linking obesity and depression subtypes. Cogn. Affect. Behav. Neurosci. 2018;18(6):1121&#x2013;1144. doi: 10.3758/s13415-018-0626-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13415-018-0626-0</ArticleId><ArticleId IdType="pubmed">30112671</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun P, Gobbo S, Caputi V, Spagnol L, Schirato G, Pasqualin M, et al. Toll like receptor-2 regulates production of glial-derived neurotrophic factors in murine intestinal smooth muscle cells. Mol. Cell Neurosci. 2015;68:24&#x2013;35. doi: 10.1016/j.mcn.2015.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.03.018</ArticleId><ArticleId IdType="pubmed">25823690</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasset E, Burcelin R. The gut microbiota to the brain axis in the metabolic control. Rev. Endocr. Metab. Disord. 2019;20(4):427&#x2013;438. doi: 10.1007/s11154-019-09511-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-019-09511-1</ArticleId><ArticleId IdType="pmc">PMC6938794</ArticleId><ArticleId IdType="pubmed">31656993</ArticleId></ArticleIdList></Reference><Reference><Citation>Letchumanan G, Abdullah N, Marlini M, Baharom N, Lawley B, Omar MR, et al. Gut microbiota composition in prediabetes and newly diagnosed type 2 diabetes: A systematic review of observational studies. Front Cell. Infect. Microbiol. 2022;12:943427. doi: 10.3389/fcimb.2022.943427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.943427</ArticleId><ArticleId IdType="pmc">PMC9422273</ArticleId><ArticleId IdType="pubmed">36046745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilholm C, Manoharan L, Roth B, D'Amato M, Ohlsson B. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels. United Eur. Gastroenterol. J. 2022;10(4):363&#x2013;375. doi: 10.1002/ueg2.12227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ueg2.12227</ArticleId><ArticleId IdType="pmc">PMC9103372</ArticleId><ArticleId IdType="pubmed">35484927</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 2023;20(5):281&#x2013;282. doi: 10.1038/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouquier J, Moreno Huizar N, Donnelly J, Glickman C, Kang DW, Maldonado J, Jones RA, Johnson K, Adams JB, Krajmalnik-Brown R, Lozupone C. The gut microbiome in autism: study-site effects and longitudinal analysis of behavior change. Msystems. 2021;6(2):e00848&#x2013;e920. doi: 10.1128/mSystems.00848-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00848-20</ArticleId><ArticleId IdType="pmc">PMC8546984</ArticleId><ArticleId IdType="pubmed">33824197</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, et al. Changes in gut and plasma microbiome following exercise challenge in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS One. 2015;10(12):e0145453. doi: 10.1371/journal.pone.0145453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145453</ArticleId><ArticleId IdType="pmc">PMC4684203</ArticleId><ArticleId IdType="pubmed">26683192</ArticleId></ArticleIdList></Reference><Reference><Citation>Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, et al. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed. Pharmacother. 2021;133:110947. doi: 10.1016/j.biopha.2020.110947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110947</ArticleId><ArticleId IdType="pmc">PMC7657099</ArticleId><ArticleId IdType="pubmed">33197765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarelli A, Giancola ML, Fontana A, Piselli P, Binda E, Trivieri N, et al. Gut microbiota composition in COVID-19 hospitalized patients with mild or severe symptoms. Front. Microbiol. 2022;13:1049215. doi: 10.3389/fmicb.2022.1049215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1049215</ArticleId><ArticleId IdType="pmc">PMC9763305</ArticleId><ArticleId IdType="pubmed">36560946</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, et al. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci. Technol. 2022;120:174&#x2013;192. doi: 10.1016/j.tifs.2021.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2021.12.033</ArticleId><ArticleId IdType="pmc">PMC8720301</ArticleId><ArticleId IdType="pubmed">35002079</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>